Related Experiment Video
Updated: May 28, 2026
09:35
A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
Skp2 is required for incretin hormone-mediated β-cell proliferation
Shuen-Ing Tschen1, Senta Georgia, Sangeeta Dhawan
1Department of Medicine, University of California, Los Angeles, Los Angeles, California 90095-7073, USA.
Molecular Endocrinology (Baltimore, Md.)
|October 8, 2011
Summary
Glucagon-like peptide-1 (GLP-1) promotes beta-cell proliferation by regulating Skp2, a protein that degrades p27. Loss of Skp2 blocks this effect, highlighting Skp2
Area of Science:
- Endocrinology
- Molecular Biology
- Cell Biology
Background:
- Glucagon-like peptide-1 (GLP-1) and exendin-4 (Ex-4) are key hormones that stimulate beta-cell growth.
- Understanding the molecular mechanisms regulating beta-cell proliferation is crucial for diabetes research.
Purpose of the Study:
- To investigate the role of Skp2 in GLP-1-induced beta-cell proliferation.
- To elucidate the signaling pathways involved in GLP-1-mediated Skp2 regulation and p27 degradation.
Main Methods:
- In vitro studies involving GLP-1 treatment of cells.
- In vivo studies using genetic manipulation (Skp2 loss).
- Pharmacological inhibition of phosphatidylinositol 3-kinase (PI3K) and Irs2 silencing RNA.
Main Results:
- GLP-1 treatment increases Skp2 levels, leading to accelerated p27 degradation in vitro.
- Loss of Skp2 in vivo abrogates GLP-1-induced beta-cell proliferation.
- The Irs2-PI3K pathway mediates GLP-1's effect on Skp2-dependent p27 degradation.
- Aged islets show reduced p27 but impaired GLP-1 response due to p16(Ink4a) accumulation, though ductal cells proliferate.
Conclusions:
- Skp2 is essential for glucoincretin-induced beta-cell proliferation.
- The Irs2-PI3K pathway is critical for regulating Skp2 activity in response to GLP-1.
- Age-related factors like p16(Ink4a) can impede beta-cell proliferation despite preserved Skp2-p27 regulation.
Related Concept Videos
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:05Insulin Secretory Vesicles
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
01:58Cell Specific Gene Expression
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
01:24Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...